Welcome Comparative Effectiveness Research on Cancer in Texas (CERCIT)
CERCIT is a multidisciplinary consortium of investigators at the University of Texas Medical Branch (UTMB), MD Anderson Cancer Center, Rice University and the Texas Department of State Health Services Texas Cancer Registry. CERCIT is funded by the Cancer Prevention Research Institute of Texas (CPRIT).
Cervical Health Awareness
UTMB's Dr. Ana Rodriguez was interviewed on Univision, January 2016
January was Cervical Health Awareness Month. UTMB's Dr. Ana Rodriguez was interviewed on Houston Spanish-language television station Univision about the need for women to get screened for cervical cancer and for boys and girls to get vaccinated against the human papillomavirus (HPV) in order to prevent cervical cancer.
by Ana M. Rodriguez, MD, Jan 2016
January is Cervical Health Awareness Month – a time to focus public attention on the need for women across the country to get screened for cervical cancer and for boys and girls to get vaccinated against the human papillomavirus when they are eligible. Read more.
TMC News, Jan 2016
Despite improvements in diagnoses and treatments, survival rates for women younger than 50 with primary, invasive endometrial cancer are not improving according to a study available online in the Journal of Cancer Research and Clinical Oncology. Read more.
2015 CERCIT Publications
|Austin MT, Nguyen H, Eberth JM, Chang Y, Heczey A, Hughes DP, Lally KP, & Elting LS. Health disparities are important determinants of outcome for children with solid tumor malignancies. J Pediatr Surg, 2015 Jan 50(1), 161-166.||PMID25598116|
|Chavez-MacGregor M, Niu J, Zhang N, Elting LS, Smith BD, Banchs J, Hortobagyi GN, & Giordano SH. Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer. J Clin Oncol, 2015 Jul 1 33(19), 2176-2183.||PMID25964256|
|Cooper AB, Parmar AD, Riall TS, Hall BL, Katz MH, Aloia TA, & Pitt HA. Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates? J Gastrointest Surg, 2015 Jan 19(1), 80-86; discussion 86-87.||PMID25091851|
|Gomez DR, Liao KP, Swisher SG, Blumenschein GR, Erasmus JJ, Jr., Buchholz TA, Giordano SH, & Smith BD. Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival. Radiother Oncol, 2015 May 115(2), 257-263.|
|Guadagnolo BA, Liao KP, Giordano SH, Elting LS, & Shih YC. Variation in Intensity and Costs of Care by Payer and Race for Patients Dying of Cancer in Texas: An Analysis of Registry-linked Medicaid, Medicare, and Dually Eligible Claims Data. Med Care, 2015 Jul 53(7), 591-598.||PMID26067883|
|He W, Zhao H, Chan W, Lopez D, Shroff RT, & Giordano SH. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer. Surgery, 2015 Jun 29.||PMID26138347|
|Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, Pierce LJ, Kronowitz SJ, & Smith BD. Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-based Analysis. Ann Surg, 2015 Apr 14.||PMID25876011|
|Nayak P, Paxton RJ, Holmes H, Thanh Nguyen H, & Elting LS. Racial and ethnic differences in health behaviors among cancer survivors. Am J Prev Med, 2015 Jun 48(6), 729-736.||PMID25998923|
|Riall TS, Adhikari D, Parmar AD, Linder SK, Dimou FM, Crowell W, Tamirisa NP, Townsend CM, Jr., & Goodwin JS. The risk paradox: use of elective cholecystectomy in older patients is independent of their risk of developing complications. J Am Coll Surg, 2015 Apr 220(4), 682-690.||PMID25660731|
|Smith BD. When is good enough really good enough? Defining the role of radiation in low-risk ductal carcinoma in situ. J Clin Oncol, 2015 Mar 1 33(7), 686-691.||PMID25605858|
|Smith GL, Huo J, Giordano SH, Hunt KK, Buchholz TA, & Smith BD. Utilization and Outcomes of Breast Brachytherapy in Younger Women. Int J Radiat Oncol Biol Phys, 2015 Sep 1 93(1), 91-101.||PMID26279027|
|Smith GL, Jiang J, Giordano SH, Meyer LA, & Eifel PJ. Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011. Int J Radiat Oncol Biol Phys, 2015 Jun 1 92(2), 260-267.||PMID25968823|
|Tamirisa NP, Parmar AD, Vargas GM, Mehta HB, Kilbane EM, Hall BL, Pitt HA, & Riall TS. Relative Contributions of Complications and Failure to Rescue on Mortality in Older Patients Undergoing Pancreatectomy. Ann Surg, 2015 Jan 5.||PMID25563871|
|Tamirisa NP, Sheffield KM, Parmar AD, Zimmermann CJ, Adhikari D, Vargas GM, Kuo YF, Goodwin JS, & Riall TS. Surgeon and Facility Variation in the Use of Minimally Invasive Breast Biopsy in Texas. Ann Surg, 2015 Jul 262(1), 171-178.||PMID25185475|
Workshop: Multi-PI Grants
Presented by James S. Goodwin, MD and others at UTMB
CERCIT Workshop August 2014
Fun with Medicare Part D Data presented by James S. Goodwin, MD
CERCIT Workshop August 2014
Shared Decision Making in Cancer Care presented by Nina Tamirisa, MD
CERCIT Workshop June 2014
The use of surgery in the elderly for management of metastatic epidural spinal cord compression presented by Justin E. Bird, MD
CERCIT Workshop June 2014
Population-based assessment of breast reconstruction presented by Ben Smith, MD
Reports and Special Publications
Surveillance Patterns Following Lung Cancer Resection [PDF]: This report describes the current population-based trends in surveillance practices and the use of these modalities in patients with non-small cell lung cancer (NSCLC) following curative resection.
Comparative Effectiveness of MRI vs. Mammography Alone in Patients Undergoing Breast-Conserving Therapy for Breast Cancer [PDF]: This report compares the effectiveness of MRI vs. mammography alone in patients undergoing breast-conserving therapy for breast cancer
Hispanic Cancer Report [PDF]: From A quarterly publication of the Texas Public Health Association (TPHA) Supplement, Fall 2013, A Comprehensive Report on Cancer among Hispanics in Texas.
CERCIT Featured in the Texas Public Health Journal Summer 2013
Using research to keep Texans informed about cancer care – that is at the heart of CERCIT (Comparative Effectiveness Research on Cancer in Texas). A description of this project and selected articles from its four research areas are featured in the Spring 2013 issue of the Texas Public Health Journal, a quarterly publication of the Texas Public Health Association (pages 22-55):
Just how much does cancer cost in Texas? [PDF] Texas Public Health Journal, Vol 63, Issue 4, Fall 2011. Findings are reported in the Cost of Cancer in Texas, 2005 [PDF] published by the Texas Cancer Council.